E-GEOD-4056 - Expression profiling of human primary breast cancer tissue before treatment with gemcitabine, epirubicine and docetaxel

Status
Released on 21 January 2006, last updated on 27 June 2012
Organism
Homo sapiens
Samples (380)
Array (1)
Protocols (3)
Description
Gene expression profiles of human breast cancer tissues from 100 different patients treated with primary systemic chemotherapy (Gemcitabine, Epirubicin and Docetaxel) Keywords: expression profiling Human breast cancer tissues from 100 patients have been used to perform expression profiling analysis.
Experiment type
transcription profiling by array 
Contacts
Andreas Schneeweiss, Axel Benner, Grischa Toedt, Meinhard Hahn, Olaf Thuerigen, Patrick Warnat, Peter Lichter
Citation
Gene expression signature predicting pathologic complete response with gemcitabine, epirubicin, and docetaxel in primary breast cancer. Thuerigen O, Schneeweiss A, Toedt G, Warnat P, Hahn M, Kramer H, Brors B, Rudlowski C, Benner A, Schuetz F, Tews B, Eils R, Sinn HP, Sohn C, Lichter P. , Europe PMC 16622258
MIAME
PlatformsProtocolsVariablesProcessedRaw
Files
Investigation descriptionE-GEOD-4056.idf.txt
Sample and data relationshipE-GEOD-4056.sdrf.txt
Processed data (1)E-GEOD-4056.processed.1.zip
Array designA-GEOD-3367.adf.txt
Links